The First Affiliated Hospital of Xiamen University
🇨🇳China
Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC
Phase 2
Not yet recruiting
- Conditions
- Lung Neoplasms
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-11
- Target Recruit Count
- 59
- Registration Number
- NCT04425135
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Not Applicable
Recruiting
- Conditions
- MetastasisTumor, SolidPositron-Emission Tomography
- Interventions
- Diagnostic Test: 18F-FDG and 68Ga-DOTA-FAPI -04 PET/CT
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2023-08-08
- Target Recruit Count
- 3000
- Registration Number
- NCT04416165
- Locations
- 🇨🇳
First affiliated hospital of xiamen university, XiaMen, Fujian, China
Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-05-15
- Target Recruit Count
- 30
- Registration Number
- NCT04389151
- Locations
- 🇨🇳
Yefeng, Xiamen, Fujian, China
Time Restricted Feeding on Impaired Glucose Regulation(TRIG Trial)
Not Applicable
Recruiting
- Conditions
- Time-Restricted FeedingImpaired Glucose RegulationOverweight/Obese
- Interventions
- Behavioral: Time Restricted Feeding(TRF)Behavioral: Reduced Calorie Diet (RCD)
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2023-08-22
- Target Recruit Count
- 140
- Registration Number
- NCT03802253
- Locations
- 🇨🇳
The first affiliated hospital of Xiamen university, Xiamen, Fujian, China
A Nurse Cohort Study in Xiamen, China
Recruiting
- Conditions
- Hypertension
- Interventions
- Other: No intervention
- First Posted Date
- 2019-01-10
- Last Posted Date
- 2023-11-03
- Target Recruit Count
- 10000
- Registration Number
- NCT03799653
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Time-Restricted Feeding(TRF) on Overweight/Obese Women with Polycystic Ovarian Syndrome (PCOS)
Not Applicable
Completed
- Conditions
- Polycystic Ovary Syndrome (PCOS)Overweight and Obesity
- Interventions
- Behavioral: Time Restricted FeedingBehavioral: Usual care
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2025-02-18
- Target Recruit Count
- 93
- Registration Number
- NCT03792282
- Locations
- 🇨🇳
The first afilliated hospital of Xiamen university, Xiamen, Fujian, China
Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes
Phase 4
- Conditions
- T2DM
- Interventions
- Drug: CSII+VildagliptinDrug: CSII(insulin Lispro)
- First Posted Date
- 2018-06-20
- Last Posted Date
- 2018-06-20
- Target Recruit Count
- 400
- Registration Number
- NCT03563794
- Locations
- 🇨🇳
The first afilliated hospital of Xiamen university, Xiamen, Fujian, China
Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial
- Conditions
- Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2018-05-22
- Target Recruit Count
- 20
- Registration Number
- NCT03531931
- Locations
- 🇨🇳
First affiliated hospital of xiamen university, XiaMen, Fujian, China
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission
Not Applicable
Recruiting
- Conditions
- Axial Spondyloarthritis
- Interventions
- Drug: To withdraw NSAIDs therapyDrug: To continue NSAIDs therapy
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2022-04-18
- Target Recruit Count
- 140
- Registration Number
- NCT03425812
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Phase 4
Recruiting
- Conditions
- Type 2 Diabetes PatientsOverweight and ObesityHyperglycaemia (Diabetic)
- Interventions
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2025-01-13
- Target Recruit Count
- 164
- Registration Number
- NCT03087032
- Locations
- 🇨🇳
The first afilliated hospital of Xiamen university, Xiamen, Fujian, China
© Copyright 2025. All Rights Reserved by MedPath